Sekar Kathiresan - Jun 17, 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Sekar Kathiresan
Stock symbol
VERV
Transactions as of
Jun 17, 2021
Transactions value $
$47,500
Form type
4
Date filed
6/21/2021, 06:20 PM
Previous filing
Jun 16, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Purchase $47.5K +2.5K +0.62% $19.00 407K Jun 21, 2021 Direct
holding VERV Common Stock 81K Jun 17, 2021 Kathiresan Family 2021 Irrevocable Trust
holding VERV Common Stock 81K Jun 17, 2021 Sekar Kathiresan 2021 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Award $0 +54K $0.00 54K Jun 17, 2021 Common Stock 54K $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 17, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 17, 2025.